Abstract
BACKGROUND: Patients with systemic lupus erythematosus (SLE) are highly susceptible to severe infections, with non-typhoidal Salmonella (NTS) often progressing to life-threatening bacteremia. However, the mechanisms underlying this heightened vulnerability remain unclear. Lipid droplets (LDs), key immunometabolic hubs, have been implicated in facilitating Salmonella survival within phagocytes. We identified the tRNA-derived small RNA (tsRNA) tRF-His-GTG-1 as upregulated in SLE and correlated with disease activity. This study investigates the signaling and functional roles of tRF-His-GTG-1 in LD formation and Salmonella persistence in SLE. METHODS: LDs and tRF-His-GTG-1 expression were analyzed in peripheral blood mononuclear cells (PBMCs) from SLE patients with or without NTS bacteremia and from controls. Bacterial survival, tsRNA function, and signaling pathways were assessed using immunofluorescence, qRT-PCR, colony-forming unit assays, and pharmacological or genetic inhibition. RESULTS: LDs were elevated in SLE PBMCs and further increased by NTS infection, correlating with enhanced bacterial survival. SLE immune complexes (ICs) and IC-primed platelet-derived extracellular vesicles (pEVs) induced LD formation via FcγRIIA-mediated uptake and Toll-like receptor (TLR) 7/8 activation. Both SLE ICs and NTS infection upregulated tRF-His-GTG-1. Mechanistically, tRF-His-GTG-1 directly bound to TLR7/8, activating ERK/p38 signaling to induce PPARδ expression and LD biogenesis. Concurrently, tRF-His-GTG-1 promoted ERK/p38 phosphorylation and IL-10 production. Inhibition of tRF-His-GTG-1 suppressed both LD- and IL-10-dependent pathways, thereby reducing Salmonella survival. CONCLUSIONS: tRF-His-GTG-1 enhances Salmonella persistence through a TLR7/8-ERK/p38-PPARδ/IL-10 signaling axis. These findings identify a tsRNA-mediated immunometabolic mechanism linking SLE with bacterial susceptibility and highlight tRF-His-GTG-1 as a potential therapeutic target to improve antibacterial immunity in high-risk patients.